Han Xu, Nieman Marvin T, Kerlin Bryce A
Department of Pharmacology Case Western Reserve University Cleveland OH USA.
Center for Clinical and Translational Research Abigail Wexner Research Institute at Nationwide Children's Hospital Columbus OH USA.
Res Pract Thromb Haemost. 2020 Dec 6;5(1):17-26. doi: 10.1002/rth2.12454. eCollection 2021 Jan.
Proteases are important regulators of cell behavior, survival, and apoptosis. They communicate to cells directly through a special class of G-protein-coupled receptors known as protease-activated receptors (PARs). N-terminal PAR proteolysis unmasks a neo-N-terminus, which serves as a tethered ligand to activate PARs. Using this unique irreversible activation mechanism, PARs relay information across cell membranes. The year 2020 is the 30th year since discovery of the first member of this family, PAR1. In this illustrated review, we highlight achievements in the PAR field over the past 3 decades. Additionally, the known expression profiles of PARs in human tissues and across species are portrayed. We also illustrate the tethered ligand activation mechanism, which is unique to PARs, and PAR regulatory mechanisms. PAR1 was originally named "thrombin receptor" because thrombin was the first protease identified to activate PAR1. However, over the past 30 years, a growing number of proteases have been found to cleave PARs and trigger differential downstream signaling depending on cleavage site, cell type, and species. We exemplify the diversity of PAR1-mediated signaling outcomes in platelets and endothelial cells as pertinent examples to the hemostasis, thrombosis, and vascular biology fields. Further, the termination and regulation of PAR signaling via endocytosis and currently available pharmacologic approaches are depicted. We conclude with portrayal of clinically translational aspects of PAR biology including pharmacologic manipulation and single-nucleotide polymorphisms.
蛋白酶是细胞行为、存活和凋亡的重要调节因子。它们通过一类特殊的G蛋白偶联受体(称为蛋白酶激活受体,PARs)直接与细胞进行通讯。PARs的N端蛋白水解会暴露出一个新的N端,该N端作为一种拴系配体来激活PARs。利用这种独特的不可逆激活机制,PARs在细胞膜间传递信息。2020年是该家族首个成员PAR1被发现的第30年。在这篇图文并茂的综述中,我们重点介绍了PAR领域在过去30年中的成就。此外,还描绘了PARs在人体组织和不同物种中的已知表达谱。我们还阐述了PARs特有的拴系配体激活机制以及PAR调节机制。PAR1最初被命名为“凝血酶受体”,因为凝血酶是首个被鉴定出可激活PAR1的蛋白酶。然而,在过去30年中,人们发现越来越多的蛋白酶能够切割PARs,并根据切割位点、细胞类型和物种引发不同的下游信号传导。我们以血小板和内皮细胞中PAR1介导的信号转导结果的多样性为例,说明其在止血、血栓形成和血管生物学领域的相关情况。此外,还描述了通过内吞作用对PAR信号的终止和调节以及目前可用的药理学方法。我们最后描述了PAR生物学在临床转化方面的情况,包括药理学操作和单核苷酸多态性。